Longitudinal Assessment of Multiple Organs in Patients With Type 2 Diabetes (MODIFY )
MODIFY aims to develop an MRI-based method to identify the risk of complications in the kidneys, liver, and cardiovascular system of patients with type 2 diabetes. Between 2020 and 2022, the study recruited adults aged 18 and above who had a diagnosis of type 2 diabetes and were receiving glucose-lowering therapy from diabetes units in Liverpool, Oxford, and London in the United Kingdom. At baseline, the study included 135 participants. Participants are followed up in person at baseline, 1 month and 6 to 9 months. Participant medical records are accessed at 1, 3 and 5 years to follow up on participant outcomes.
Study design
Cohort - clinical, Cohort
Number of participants at first data collection
135 (participants)
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2020
Primary Institutions
Liverpool University Hospitals NHS Foundation Trust
Oxford University Hospitals NHS Trust
Royal Free Hospital NHS Foundation Trust
University of Liverpool
Links
clinicaltrials.gov/show/NCT04114682
hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/modify/
Profile paper DOI
cdn.clinicaltrials.gov/large-docs/82/NCT04114682/Prot_000.pdf
Funders
Perspectum
Ongoing?
Yes
Data types collected
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- None
- None
- Healthcare data
Engagement
Keywords
